Polyphenols: Multipotent therapeutic agents in neurodegenerative diseases

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Bhullar, Khushwant S ^a   Rupasinghe, H P Vasantha ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER'S DISEASE; HUNTINGTON'S DISEASE; NEURODEGENERATIVE DISORDERS; NEUROLOGICAL DISORDERS; PARKINSON'S DISEASE; THERAPEUTIC AGENTS; THERAPEUTIC OUTCOMES; THERAPEUTIC TARGETS;

NEUROLOGY; PSYCHOPHYSIOLOGY;

NEURODEGENERATIVE DISEASES;

7,8 DIHYDROXYFLAVONE; ACACETIN; ACETYLCHOLINESTERASE; APIGENIN; BAICALEIN; BAICALIN; CAFFEIC ACID; CURCUMIN; EPIGALLOCATECHIN GALLATE; FERULIC ACID; FISETIN; HESPERETIN; HESPERIDIN; KAEMPFEROL; LIQUIRITIGENIN; LUTEOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MORIN; MYRICETIN; NARINGENIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PICEATANNOL; POLYPHENOL; QUERCETIN; RESVERATROL; RUTOSIDE; SCOPOLAMINE; STAT PROTEIN; TANNIN; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DIETARY INTAKE; DISEASE ASSOCIATION; DOWN REGULATION; DRUG BIOAVAILABILITY; DRUG INDUCED DISEASE; ENZYME ACTIVITY; HUMAN; HUNTINGTON CHOREA; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN TARGETING; RISK REDUCTION; SIGNAL TRANSDUCTION; TEA; ANIMAL; AUTOPHAGY; CHEMISTRY; DEGENERATIVE DISEASE; DRUG EFFECT; IMMUNITY; METABOLISM; PATHOLOGY; REVIEW;

ANIMALIA;

ANIMALS; AUTOPHAGY; HUMANS; IMMUNITY; NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; POLYPHENOLS; SIGNAL TRANSDUCTION;

EID: 84879335548     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/891748     Document Type: Article

References (218)

1. Hung C. W., Chen Y. C., Hsieh W. L., Chiou S. H., Kao C. L., Ageing and neurodegenerative diseases. Ageing Research Reviews 2010 9 1 S36 S46
2. Ross C. A., Tabizi S. J., Huntington's disease: from molecular pathogenesis to clinical treatment. Lancelet Neurology 2011 10 1 83 98
3. Olesen J., Gustavsson A., Svensson M., Wittchen H. U., Jonsson B., The economic cost of brain disorders in Europe. European Journal of Neurology 2012 19 1 155 162
4. Albarracin S. L., Stab B., Casas Z., Effects of natural antioxidants in neurodegenerative diseases. Nutritional Neuroscience 2012 15 1 1 9
5. Lundkvist J., Näslund J., γ -secretase: a complex target for Alzheimer's disease. Current Opinion in Pharmacology 2007 7 1 112 118 2-s2.0-33846922600 10.1016/j.coph.2006.10.002
6. Heron M., Deaths: leading causes for 2008. National Vital Statistics Reports 2012 6 60 1 94
7. Phiel C. J., Wilson C. A., Lee V. M. Y., Klein P. S., GSK-3 regulates production of Alzheimer's disease amyloid- β peptides. Nature 2003 423 6938 435 439 2-s2.0-0038187674 10.1038/nature01640
8. Biasini E., Unterberger U., Solomon I. H., A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity. Journal of Neuroscience 2013 33 6 2408 2418
9. Zampagni M., Wright D., Cascella R., Novel s-acyl glutathione derivatives prevent amyloid oxidative stress and cholinergic dysfunction in Alzheiner disease models. Free Radical Biology and Medicine 2012 52 8 1362 1371
10. Kolarova M., Sierra F. G., Bartos A., Rincy J., Structure and pathology of tau protein in Alzheimer's disease. International Journal of Alzheimer's Disease 2012 2012 13 731526 10.1155/2012/731526
11. Mi K., Johnson G. V., The role of tau phosphorylation in pathogenesis of Alzheimer's disease. Current Alzheimer's Research 2006 3 5 449 463
12. Yang D. S., Stavrides P., Mohan P. S., Kaushik S., Kumar A., Ohno M., Schmidt S. D., Wesson D., Bandyopadhyay U., Jiang Y., Pawlik M., Peterhoff C. M., Yang A. J., Wilson D. A., St George-Hyslop P., Westaway D., Mathews P. M., Levy E., Cuervo A. M., Nixon R. A., Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits. Brain 2011 134 1 258 277 2-s2.0-78650716872 10.1093/brain/awq341
13. Swardfager W., Lanctt K., Rothenburg L., Wong A., Cappell J., Herrmann N., A meta-analysis of cytokines in Alzheimer's disease. Biological Psychiatry 2010 68 10 930 941 2-s2.0-78049419440 10.1016/j.biopsych.2010.06.012
14. Dutta R., Trapp B. D., Gene expression profiling in multiple sclerosis brain. Neurobiology of Disease 2012 45 1 108 114
15. Ziemssen T., Symptom management in patients with multiple sclerosis. Journal of Neurological Sciences 2011 311 1 S48 S52
16. Łyszczarz A. K., Szczuciński A., Pawlak M. A., Losy J., Clinical study on CXCL13, CCL17, CCL20 and IL-17 as immune cell migration navigators in relapsing-remitting multiple sclerosis patients. Journal of the Neurological Sciences 2011 300 1-2 81 85 2-s2.0-78650516882 10.1016/j.jns.2010. 09.026
17. Menezea A. R., Lavie C. J., Milani R. V., Okeefe J., The effects of statins on prevention of stoke and dementia: a review. Psychosomatics 2012 32 5 240 249
18. Luheshi N. M., Kovacs K. J., Lopez-Castejon G., Brough D., Denes A., Interleukin-1 expression precedes IL-1 β after ischemic brain injury and is localized to area of focal neuronal loss and penumbral tissues. Journal of Neuroinflammation 2011 29 8 186
19. Saver J. L., Time is brain-quantified. Stroke 2006 37 1 263 266 2-s2.0-33644874026 10.1161/01.STR.0000196957.55928.ab
20. Tuttolomondo A., Di Raimondo D., di Sciacca R., Pinto A., Licata G., Inflammatory cytokines in acute ischemic stroke. Current Pharmaceutical Design 2008 14 33 3574 3589 2-s2.0-59849127279 10.2174/138161208786848739
21. Zhang W., Potrovita I., Tarabin V., Herrmann O., Beer V., Weih F., Schneider A., Schwaninger M., Neuronal activation of NF- B contributes to cell death in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 2005 25 1 30 40 2-s2.0-11844269946 10.1038/sj.jcbfm.9600004
22. Bekris L. M., Mata I. F., Zabetian C. P., The genetics of Parkinson disease. Journal of Geriatric Psychiatry and Neurology 2010 23 4 228 242 2-s2.0-78649284891 10.1177/0891988710383572
23. Harraz M. M., Dawson T. M., Dawson V. L., MicroRNAs in Parkinson's disease. Journal of Chemical Neuroanatomy 2011 42 2 127 130
24. Reale M., Iarlori C., Thomas A., Gambi D., Perfetti B., Di Nicola M., Onofrj M., Peripheral cytokines profile in Parkinson's disease. Brain, Behavior, and Immunity 2009 23 1 55 63 2-s2.0-56849086964 10.1016/j.bbi.2008.07.003
25. Menza M., Dobkin R. D., Marin H., Mark M. H., Gara M., Bienfait K., Dicke A., Kusnekov A., The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease. Psychosomatics 2010 51 6 474 479 2-s2.0-78649686234 10.1176/appi.psy.51.6.474
26. Exner N., Lutz A. K., Haass C., Winklhofer K. F., Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. The EMBO Journal 2012 31 14 3038 3062
27. Hedskog L., Zhang S., Ankarcrona M., Strategic role for mitochondria in Alzheimer's disease and cancer. Antioxidants and Redox Signaling 2012 16 12 1476 1491
28. Van Horssen J., Witte M., Ciccarelli O., The role of mitochondria in axonal degeneration and tissue repair. Multiple Sclerosis 2012 18 8 1058 1067
29. Pandya J. D., Sullivan P. G., Pettigrew L. C., Focal cerebral ischemia and mitochondrial dysfunction in the TNF -transgenic rat. Brain Research 2011 1384 151 160 2-s2.0-79953025427 10.1016/j.brainres.2011.01.102
30. Blanco S., Suarez A., Gandia-Pla S., Gómez-Llorente C., Antúnez A., Gómez-Capilla J. A., Fárez-Vidal M. E., Use of capillary electrophoresis for accurate determination of CAG repeats causing Huntington disease. An oligonucleotide design avoiding shadow bands. Scandinavian Journal of Clinical and Laboratory Investigation 2008 68 7 577 584 2-s2.0-55249123452 10.1080/00365510801915171
31. Wild E., Magnusson A., Lahiri N., Abnormal peripheral chemokine profile in Huntington's disease. PLOS Currents 2011 3 RRN1231 10.1371/currents.RRN1231
32. Duffy F. H., Albert M. S., McAnulty G., Brain electrical activity in patients with presenile and senile dementia of the Alzheimer type. Annals of Neurology 1984 16 4 439 448 2-s2.0-0021123715
33. + channels designed for high-frequency repetitive firing. Trends in Neurosciences 2001 24 9 517 526 2-s2.0-0035451064 10.1016/S0166-2236(00)01892-0
34. Boda E., Hoxha E., Pinni A., Montarolo F., Tempia F., Brain expression of Kv3 subunits during development, adulthood and aging and in a murine model of Alzheimer's disease. Journal of Molecular Neuroscience 2012 46 6 606 615
35. Judge S. I. V., Lee J. M., Bever C. T., Hoffman P. M., Voltage-gated potassium channels in multiple sclerosis: overview and new implications for treatment of central nervous system inflammation and degeneration. Journal of Rehabilitation Research and Development 2006 43 1 111 122 2-s2.0-33745292972 10.1682/JRRD.2004.09.0116
36. Smith K. J., Sodium channels and multiple sclerosis: roles in symptom production, damage and therapy. Brain Pathology 2007 17 2 230 242 2-s2.0-33947546463 10.1111/j.1750-3639.2007.00066.x
37. Black J. A., Newcombe J., Waxman S. G., Astrocytes within multiple sclerosis lesions upregulate sodium channel Nav1.5. Brain 2010 133 3 835 846 2-s2.0-77950223688 10.1093/brain/awq003
38. Stiefelhagen P., Treatment of Parkinson's disease, epilepsy and pain with electrical impulses when drugs are inadequate. MMW-Fortschritte der Medizin 2003 145 48 14 2-s2.0-0345714642
39. Surmeier D. J., Schumacker P. T., Calcium, bioenergetics and neuronal vulnerability in Parkinson's disease. The Journal of Biological Chemistry 2013 288 15 10736 10741
40. Oyama F., Miyazaki H., Sakamoto N., Becquet C., Machida Y., Kaneko K., Uchikawa C., Suzuki T., Kurosawa M., Ikeda T., Tamaoka A., Sakurai T., Nukina N., Sodium channel β 4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice. Journal of Neurochemistry 2006 98 2 518 529 2-s2.0-33746530608 10.1111/j.1471-4159.2006. 03893.x
41. Ariano M. A., Cepeda C., Calvert C. R., Flores-Hernández J., Hernández-Echeagaray E., Klapstein G. J., Chandler S. H., Aronin N., DiFiglia M., Levine M. S., Striatal potassium channel dysfunction in Huntington's disease transgenic mice. Journal of Neurophysiology 2005 93 5 2565 2574 2-s2.0-20244376896 10.1152/jn.00791.2004
42. Small G., Bullock R., Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease. Alzheimer's and Dementia 2011 7 2 177 184
43. Lampl C., You X., Limmroth V., Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age. European Journal of Neurology 2012 19 1 142 148
44. Singer C., Managing the patient with newly diagnosed Parkinson's disease. Cleveland Clinical Journal of Medicine 2012 79 2 S3 S7
45. Tommaso M., Serpino C., Sciruicchio V., Management of Huntington's disease: role of tetrabenazine. Therapeutics and Clinical Risk Management 2011 7 123 129
46. Haile W. B., Wu J., Echeverry R., Wu F., An J., Yepes M., Tissue type plasminogen activator has a neuroprotective effect in the ischemic brain mediated by neuronal TNF Journal of Cerebral Blood Flow and Metabolism 2012 32 1 57 59
47. Faria A., Pestana D., Teixeira D., Azevedo J., De Freitas V., Mateus N., Calhau C., Flavonoid transport across RBE4 cells: a blood-brain barrier model. Cellular and Molecular Biology Letters 2010 15 2 234 241 2-s2.0-77954577365 10.2478/s11658-010-0006-4
48. Basli A., Soulet S., Chaher N., Wine polyphenols: potential agents in neuroprotection. Oxidative Medicine and Cellular Longevity 2012 2012 14 805762 10.1155/2012/805762
49. Pérez-Jiménez J., Neveu V., Vos F., Scalbert A., Identification of the 100 richest dietary sources of polyphenols: an application of the Phenol-Explorer database. European Journal of Clinical Nutrition 2010 64 3 S112 S120 2-s2.0-78149248083 10.1038/ejcn.2010.221
50. Cieslik E., Greda A., Adamus W., Contents of polyphenols in fruit and vegetables. Food Chemistry 2006 94 1 135 142
51. Jones Q. R., Warford J., Rupasinghe H. P. V., Robertson G. S., Target-based selection of flavonoids for neurodegenerative disorders. Trends in Pharmacological Sciences 2012 33 11 602 610
52. Thilakarathna S. H., Rupasinghe H. P. V., Needs P. W., Apple peel bioactive rich extracts effectively inhibit in vitro human LDL oxidation. Food Chemistry 2013 138 1 463 470
53. Okello E. J., Leylabi R., McDougall J., Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites. Food and Function 2012 3 6 651 661
54. Qin X. Y., Cheng Y., Yu L. C., Potential protection of green tea polyphenols against intracellular amyloid beta induced toxicity on primary cultured prefrontal cortical neurons of rats. Neuroscience Letters 2012 513 2 170 173
55. Wang J., Ferruzzi M. G., Ho L., Brain-targeted proanthocyandinin metabolites for Alzheimer's disease treatment. Journal of Neuroscience 2012 32 15 5144 5150
56. Liu P., Kemper L. J., Wang J., Zahs K. R., Ashe K. H., Pasinetti G. M., Grape seed polyphenolic extract specifically decreases A β 56 in the brains of Tg2576 mice. Journal of Alzheimer's Disease 2011 26 4 657 666
57. Reding H. K., Ho L., Santa-Maria I., Diaz-Ruiz C., Wang J., Pasinetti G. M., Ultrastructural alterations of Alzheimer's disease paired helical filaments by grape seed-derived polyphenols. Neurobiology of Aging 2012 33 7 1427 1439 2-s2.0-78650634637 10.1016/j.neurobiolaging.2010.11.006
58. Wang T., Gu J., Wu P. F., Wang F., Xiong Z., Yang Y. J., Wu W. N., Dong L. D., Chen J. G., Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF- B pathways and inhibition of intracellular ROS/RNS generation. Free Radical Biology and Medicine 2009 47 3 229 240 2-s2.0-67349106386 10.1016/j.freeradbiomed.2009.02.027
59. Thomas P., Wang Y. J., Zhong J. H., Kosaraju S., O'Callaghan N. J., Zhou X. F., Fenech M., Grape seed polyphenols and curcumin reduce genomic instability events in a transgenic mouse model for Alzheimer's disease. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis 2009 661 1-2 25 34 2-s2.0-58849109761 10.1016/j.mrfmmm.2008.10.016
60. Feng Y., Wang X. P., Yang S. G., Wang Y. J., Zhang X., Du X. T., Sun X. X., Zhao M., Huang L., Liu R. T., Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. NeuroToxicology 2009 30 6 986 995 2-s2.0-71249124418 10.1016/j.neuro.2009.08.013
61. Huang T. C., Lu K. T., Wo Y. Y., Wu Y. J., Yang Y. L., Resveratrol protects rats from A β induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS ONE 2011 6 12 e29102
62. Frozza R. L., Bernardi A., Paese K., Hoppe J. B., Da Silva T., Battastini A. M. O., Pohlmann A. R., Guterres S. S., Salbego C., Characterization of trans-resveratrol-loaded lipid-core nanocapsules and tissue distribution studies in rats. Journal of Biomedical Nanotechnology 2010 6 6 694 703 2-s2.0-79953020260 10.1166/jbn.2010.1161
63. Ushikubo H., Watanabe S., Tanimoto Y., 3, 3′ 4′ 5, 5′ Pentahyroxyflavone is a potent inhibitor of amyloid β fibril formation. Neuroscience Letters 2012 513 1 51 56
64. Gong E. J., Park H. R., Kim M. E., Morin attenuates tau hyperphosphorylation by inhibiting GSK3 β Neurobiology of Disease 2011 44 2 223 230
65. Mori T., Rezai-Zedeh K., Koyama N., Tannic acid is a natural β -secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. The Journal of Biological Chemistry 2012 287 9 6912 6927
66. Devi L., Ohno M., 7, 8-dihyroxyflavone, a small molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease. Neuropsychopharmacology 2012 37 2 434 444
67. Liu R. T., Tang J. T., Zhou L. B., Fu J. Y., Lu Q. J., Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms. European Journal of Pharmacology 2011 669 1-3 76 83
68. Jiménez-Aliaga K., Bermejo-Bescs P., Benedí J., Martín-Aragón S., Quercetin and rutin exhibit antiamyloidogenic and fibril-diasggregating effects in vitro and potent antioxidant activity in APPswe cells. Life Sciences 2011 89 25-26 939 945
69. Richetti S. K., Blank M., Capiotti K. M., Piato A. L., Bogo M. R., Vianna M. R., Bonan C. D., Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behavioural Brain Research 2011 217 1 10 15 2-s2.0-78149273255 10.1016/j.bbr.2010.09.027
70. Gupta R., Gupta L. K., Mediratta P. K., Bhattacharya S. K., Effect of resveratrol on scopolamine induced cognitive impairment in mice. Pharmacological Reports 2012 64 2 438 444
71. Wang S. W., Wang Y. J., Su Y. J., Rutin inhibits β -amyloid aggregation and cytotoxicity, attenuates oxidative stress and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology 2012 33 3 482 490
72. Jagota S., Rajadas J., Effect of phenolic compounds against A β aggregation and A β -induced toxicity in transgenic C. elegans. Neurochemical Research 2012 37 1 40 48
73. Sievers C., Meira M., Hoffmann F., Fontoura P., Kappos L., Lindberg R. L., Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clinical Immunology 2012 144 1 70 79
74. Fonseca-Kelly Z., Nassrallah M., Uribe J., Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis. Frontiers in Neurology 2012 3 84
75. Shindler K. S., Ventura E., Dutt M., Elliott P., Fitzgerald D. C., Rostami A., Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. Journal of Neuro-Ophthalmology 2010 30 4 328 339 2-s2.0-78650482951 10.1097/WNO.0b013e3181f7f833
76. Ho D. J., Calingasan N. Y., Wille E., Dumont M., Beal M. F., Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Experimental Neurology 2010 225 1 74 84 2-s2.0-77955660387 10.1016/j.expneurol. 2010.05.006
77. Sternberg Z., Chadha K., Lieberman A., Hojnacki D., Drake A., Zamboni P., Rocco P., Grazioli E., Weinstock-Guttman B., Munschauer F., Quercetin and interferon- β modulate immune response(s) in peripheral blood mononuclear cells isolated from multiple sclerosis patients. Journal of Neuroimmunology 2008 205 1-2 142 147 2-s2.0-56349138961 10.1016/j.jneuroim.2008.09.008
78. Herges K., Millward J. M., Hentschel N., Infante-Duarte C., Aktas O., Zipp F., Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation. PLoS ONE 2011 6 10 e25456
79. Davis J. M., Murphy E. A., Carmichael M. D., Davis B., Quercetin increases brain and muscle mitochondrial biogenesis and exercise tolerance. American Journal of Physiology 2009 296 4 R1071 R1077 2-s2.0-65949090502 10.1152/ajpregu.90925.2008
80. Xiang L., Sun K., Lu J., Weng Y., Taoka A., Sakagami Y., Qi J., Anti-aging effects of phloridzin, an apple polyphenol, on yeast via the SOD and Sir2 genes. Bioscience, Biotechnology and Biochemistry 2011 75 5 854 858 2-s2.0-79957805859 10.1271/bbb.100774
81. Hong K. S., Park J. I., Kim M. J., Involvement of SIRT1 in hypoxic down-regulation of c-Myc and β -catechin and hypoxic precondition effect of polyphenol. Toxicology and Applied Pharmacology 2012 259 2 210 218
82. Hendriks J. J. A., De Vries H. E., Van Der Pol S. M. A., Van Den Berg T. K., Van Tol E. A. F., Dijkstra C. D., Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochemical Pharmacology 2003 65 5 877 885 2-s2.0-0037333185 10.1016/S0006-2952(02)01609-X
83. Ashafaq M., Raza S. S., Khan M. M., Catechin hydrate ameliorates redox imbalance and limits inflammatory response in focal cerebral ischemia. Neurochemical Research 2012 37 8 1747 1760
84. Park J. W., Hong J. S., Lee K. S., Kim H. Y., Lee J. J., Lee S. R., Green tea polyphenol (-)-epigallocatechin gallate reduces matrix metalloproteinase-9 activity following transient focal cerebral ischemia. Journal of Nutritional Biochemistry 2010 21 11 1038 1044 2-s2.0-77958152067 10.1016/j.jnutbio.2009.08. 009
85. Panickar K. S., Polansky M. M., Anderson R. A., Green tea polyphenols attenuate glial swelling and mitochondrial dysfunction following oxygen-glucose deprivation in cultures. Nutritional Neuroscience 2009 12 3 105 113 2-s2.0-66349128263 10.1179/147683009X423300
86. Pandey A. K., Hazari P. P., Patnaik R., Mishra A. K., The role of ASIC1a in neuroprotection elicited by quercetin in focal cerebral ischemia. Brain Research 2011 1383 289 299 2-s2.0-79952986535 10.1016/j.brainres.2011.01.085
87. Yao Y., Han D. D., Zhang T., Yang Z., Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons. Phytotherapy Research 2010 24 1 136 140 2-s2.0-74249099539 10.1002/ptr.2902
88. Lee J. K., Kwak H. J., Piao M. S., Jang J. W., Kim S. H., Kim H. S., Quercetin reduces the elevated matrix metalloproteinases-9 level and improves functional outcome after cerebral focal ischemia in rats. Acta Neurochirurgica 2010 112 6 1477 1487 2-s2.0-79959560081
89. Pandey A. K., Verma S., Bhattacharya P., Paul S., Mishra A., Patnaik R., An in-silico strategy to explore neuroprotection by quercetin in cerebral ischemia: a novel hypothesis based on inhibition of matrix metalloproteinase (MMPs) and acid sensing ion channel 1a (ASIC1a). Medical Hypothesis 2012 79 1 76 81
90. Khan M. M., Ahmad A., Ishrat T., Khuwaja G., Srivastawa P., Khan M. B., Raza S. S., Javed H., Vaibhav K., Khan A., Islam F., Rutin protects the neural damage induced by transient focal ischemia in rats. Brain Research 2009 1292 123 135 2-s2.0-69449089391 10.1016/j.brainres.2009.07.026
91. Abd-El-Fattah A. A., El-Sawalhi M. M., Rashed E. R., El-Ghazaly M. A., Possible role of vitamin E, coenzyme Q10 and rutin in protection against cerebral ischemia/reperfusion injury in irradiated rats. International Journal of Radiation Biology 2010 86 12 1070 1078 2-s2.0-78649747639 10.3109/09553002.2010.501844
92. Li H., Yan Z., Zhu J., Yang J., He J., Neuroprotective effects of resveratrol on ischemic injury mediated by improving brain energy metabolism and alleviating oxidative stress in rats. Neuropharmacology 2011 60 2-3 252 258 2-s2.0-78650837168 10.1016/j.neuropharm.2010.09.005
93. Li C., Yan Z., Yang J., Chen H., Li H., Jiang Y., Zhang Z., Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats. Neurochemistry International 2010 56 3 495 500 2-s2.0-77049102824 10.1016/j.neuint.2009.12.009
94. Gelderblom M., Leypoldt F., Lewerenz J., The flavonoid fisetin attenuates postischemic immune cell infiltration, activation and infract size after transient cerebral middle artery occlusion in mice. Journal of Cerebral Flow and Blood Metabolism 2012 32 5 835 843
95. Tu X. K., Yang W. Z., Liang R. S., Effect of baicalin on matrix metalloproteinase-9 expression and blood brain barrier permeability following focal cerebral ischemia in rats. Neurochemical Research 2011 36 11 2022 2028
96. Cao Y., Mao X., Sun C., Zheng P., Gao J., Wang X., Min D., Sun H., Xie N., Cai J., Baicalin attenuates global cerebral ischemia/reperfusion injury in gerbils via anti-oxidative and anti-apoptotic pathways. Brain Research Bulletin 2011 85 6 396 402 2-s2.0-79960199325 10.1016/j.brainresbull.2011.05.002
97. Cui L., Zhang X., Yang R., Liu L., Wang L., Li M., Du W., Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2. Pharmacology Biochemistry and Behavior 2010 96 4 469 475 2-s2.0-77956059859 10.1016/j.pbb.2010.07.007
98. Tu X. K., Yang W. Z., Shi S. S., Baicalin inhibits TLR2/4 signaling pathway in rat brain following permanent cerebral ischemia. Inflammation 2011 34 5 463 470
99. Simao F., Matte A., Pagnussant A. S., Netto C. A., Salbego C. G., Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3 β and CREB through P13-K/Akt pathways. European Journal of Neuroscience 2012 36 7 2899 2905
100. Jin F., Wu Q., Lu Y. F., Gong Q. H., Shi J. S., Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. European Journal of Pharmacology 2008 600 1-3 78 82 2-s2.0-56149119401 10.1016/j.ejphar.2008.10.005
101. Paris D., Matura V., Ait-Ghezala G., Abdelahad D. B., Patel N., Bachmeier C., Mullan M., Flavonoids lower Alzheimer's A β production via NF B dependent mechanism. Bioinformation 2011 6 6 229 236
102. Ding B. J., Ma W. W., He L. L., Zhou X., Yuan L. H., Yu H. L., Feng J. F., Xiao R., Soybean isoflavone alleviates β -amyloid 1-42 induced inflammatory response to improve learning and memory ability by down regulation of Toll-like receptor 4 expression and nuclear factor- B activity in rats. International Journal of Developmental Neuroscience 2011 29 5 537 542 2-s2.0-79958718238 10.1016/j.ijdevneu.2011.04.002
103. Capiralla H., Vingtdeux V., Zhao H., Resveratrol mitigates lipopolysaccharide-and A β mediated microglial inflammation by inhibiting the TLR4/NF B/STAT signaling cascade. Journal of Neurochemistry 2012 120 3 461 472
104. Xu Y. W., Sun L., Liang H., Sun G. M., Cheng Y., 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR γ expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Research 2010 1307 149 157 2-s2.0-70749160209 10.1016/j.brainres.2009.10.038
105. Hou Y. C., Liou K. T., Chern C. M., Wang Y. H., Liao J. F., Chang S., Chou Y. H., Shen Y. C., Preventive effect of silymarin in cerebral ischemia-reperfusion-induced brain injury in rats possibly through impairing NF- B and STAT-1 activation. Phytomedicine 2010 17 12 963 973 2-s2.0-77956569078 10.1016/j.phymed.2010.03.012
106. Patir H., Sarada S. K., Singh S., Mathew T., Singh B., Bansal A., Quercetin as a prophylactic measure against high altitude cerebral edema. Free Radical Biology and Medicine 2012 54 4 659 668
107. Cheng G., Zhang X., Gao D., Jiang X., Dong W., Resveratrol inhibits MMP-9 expression by up-regulating PPAR expression in an oxygen glucose deprivation-exposed neuron model. Neuroscience Letters 2009 451 2 105 108 2-s2.0-58549091662 10.1016/j.neulet.2008.12.045
108. Chang J., Rimando A., Pallas M., Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease. Neurobiology of Aging 2012 33 9 2062 2071
109. Shah Z. A., Li R. C., Ahmad A. S., Kensler T. W., Yamamoto M., Biswal S., Doré S., The flavanol (-)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway. Journal of Cerebral Blood Flow and Metabolism 2010 30 12 1951 1961 2-s2.0-78649710411 10.1038/jcbfm.2010.53
110. Ren J., Fan C., Chen N., Huang J., Yang Q., Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf-2 and HO-1 in rats. Neurochemical Research 2011 36 12 2352 2362
111. Yen T. L., Hsu C. K., Lu W. J., Neuroprotective effects of Xanthohumol, a prenylated flavonoid from hops (Humulus lupus), in ischemic stroke of rats. Journal of Agricultural and Food Chemistry 2012 60 8 1937 1944
112. Agrawal M., Kumar V., Kashyap M. P., Khanna V. K., Randhawa G. S., Pant A. B., Ischemic insult induced apoptotic changes in PC12 cells: protection by trans resveratrol. European Journal of Pharmacology 2011 666 1-3 5 11 2-s2.0-79960001039 10.1016/j.ejphar.2011.05.015
113. Nones J., -Spohr T. C. E., Gomes F. C., Hesperidin, a flavone glycoside, as mediator of neuronal survival. Neurochemical Research 2011 36 10 1776 1784
114. Liu C. M., Sun Y. Z., Sun J. M., Ma J. Q., Cheng C., Protective role of quercetin lead-induced inflammatory response in rat kidney through the ROS-mediated MAPKs and NF B pathway. Biochemica et Biophysica Acta 2012 1820 10 1693 1703
115. Abraham J., Johnson R. W., Consuming a diet supplemented with resveratrol reduced infection-related neuroinflammation and deficits in working memory in aged mice. Rejuvenation Research 2009 12 6 445 453 2-s2.0-77649208936
116. Cavet M. E., Harrington K. L., Vollmer T. R., Ward K. W., Zhang J. Z., Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Molecular Vision 2011 17 533 542 2-s2.0-79952129512
117. Noh S. U., Park Y. M., The effect of green tea polyphenols on macrophage migration inhibitory factor-associated steroid resistance. The British Journal of Dermatology 2012 166 3 653 657
118. Lee E. O., Park H. J., Kang J. L., Kim H. S., Chong Y. H., Resveratrol reduces glutamate-mediated monocyte chemotactic protein-1 expression via inhibition of extracellular signal-regulated kinase 1/2 pathway in rat hippocampal slice cultures. Journal of Neurochemistry 2010 112 6 1477 1487 2-s2.0-77349084145 10.1111/j.1471-4159.2009.06564.x
119. Norata G. D., Marchesi P., Passamonti S., Pirillo A., Violi F., Catapano A. L., Anti-inflammatory and anti-atherogenic effects of cathechin, caffeic acid and trans-resveratrol in apolipoprotein E deficient mice. Atherosclerosis 2007 191 2 265 271 2-s2.0-33947188634 10.1016/j.atherosclerosis.2006.05.047
120. Qureshi A. A., Tan X., Reis J. C., Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by d-tocotrienol and quercetin. Lipids in Health and Disease 2011 10 239 1 22
121. Zhang Z. J., Cheang L. C. V., Wang M. W., Lee S. M. Y., Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. International Journal of Molecular Medicine 2011 27 2 195 203 2-s2.0-78751698755 10.3892/ijmm.2010.571
122. Skyberg J. A., Robison A., Golden S., Apple polyphenols require T cells to ameliorate dextran sulfate sodium-induced colitis and dampen proinflammatory cytokine expression. Journal of Leukocyte Biology 2011 90 6 1043 1054
123. Keddy P. G. W., Dunlop K., Warford J., Neuroprotective and anti-inflammatory effects of the flavonoid-enriched fraction AF4 in a mouse model of hypoxic-ischemia brain injury. PLoS ONE 2012 7 12 e51324
124. Bournival J., Plouffe M., Renaud J., Provencher C., Martinoli M. G., Quercetin and sesamin protects dopaminergic cells from MMP(+)-Induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system. Oxidative Stress and Cellular Longevity 2012 2012 921941
125. Li S. Y., Yang D., Fu Z. J., Woo T., Wong D., Lo A. C., Lutein enhances survival and reduces neuronal damage in a mouse model of ischemic stroke. Neurobiology of Disease 2012 45 1 624 632
126. Liu C., Wu J., Xu K., Cai F., Gu J., Ma L., Chen J., Neuroprotection by baicalein in ischemic brain injury involves PTEN/AKT pathway. Journal of Neurochemistry 2010 112 6 1500 1512 2-s2.0-77349112413 10.1111/j.1471-4159.2009. 06561.x
127. Hou C. W., Lin Y. T., Chen Y. L., Neuroprotective effects of carnosic acid on neuronal cells under ischemic and hypoxic stress. Nutritional Neuroscience 2012 15 6 257 263
128. Kao E. S., Hsu J. D., Wang C. J., Yang S. H., Cheng S. Y., Lee H. J., Polyphenols extracted from hibiscus sabdariffa L. inhibited lipopolysaccharide- induced inflammation by improving antioxidative conditions and regulating cyclooxygenase-2 expression. Bioscience, Biotechnology and Biochemistry 2009 73 2 385 390 2-s2.0-65249099586 10.1271/bbb.80639
129. Huang C. S., Lii C. K., Lin A. H., Protection by chrysin, apigenin and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes. Archives of Toxicology 2013 87 1 167 168
130. Ye Q., Ye L., Xu X., Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1a signaling pathway. BMC Complementary and Alternative Medicine 2012 28 12 82
131. Martín S., González-Burgos E., Carretero M. E., Gómez-Serranillos M. P., Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes. Food Chemistry 2011 128 1 40 48 2-s2.0-79954426079 10.1016/j.foodchem.2011.02.074
132. Fernández-Pachón M. S., Berná G., Otaolaurruchi E., Troncoso A. M., Martín F., García-Parrilla M. C., Changes in antioxidant endogeneous enzymes (activity and gene expression levels) after repeated red wine intake. Journal of Agriculture and Food Chemistry 2009 57 15 6578 6583
133. Duong T. T. H., Antao S., Ellis N. A., Myers S. J., Witting P. K., Supplementation with a synthetic polyphenol limits oxidative stress and enhances neuronal cell viability in response to hypoxia-re-oxygenation injury. Brain Research 2008 1219 8 18 2-s2.0-45849090297 10.1016/j.brainres.2008.04.044
134. Yang Y. C., Lii C. K., Lin A. H., Induction of glutathione synthesis and heme oxygenase 1 by flavonoids butein and phloretin is mediated through ERK/Nrf2 pathway and protects against oxidative stress. Free Radical Biology and Medicine 2011 51 11 2073 2081 10.1016/j.freeradbiomed.2011.09.007
135. Overman A., Chuang C. C., McIntosh M., Quercetin attenuates inflammation in human macrophages exposed to macrophage-conditioned media. International Journal of Obesity 2011 35 9 1165 1172
136. Deng G., Wang J., Zhang Q., Hepatoprotective effects of phloridzin on hepatoprotective fibrosis induced by carbon tetrachloride against stress triggered damage and fibrosis in rats. Biological and Pharmaceutical Bulletin 2012 35 7 1118 1125
137. Tufekci K. U., Meuwissen R., Genc S., Genc K., Inflammation in Parkinson's disease. Advances in Protein Chemistry and Structural Biology 2012 88 69 132
138. Khan M. M., Ahmad A., Ishrat T., Khan M. B., Hoda M. N., Khuwaja G., Raza S. S., Khan A., Javed H., Vaibhav K., Islam F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Research 2010 1328 139 151 2-s2.0-77950594327 10.1016/j.brainres.2010.02.031
139. Chao J., Yu M. S., Ho Y. S., Wang M., Chang R. C. C., Dietary
140. Kim H. Y., Lee S. M., Ferulic acid attenuates ischemia/reperfusion- induced hepatocyte apoptosis via inhibition of JNK activation. European Journal of Pharmaceutical Sciences 2012 45 5 708 705
141. Lv C., Hong T., Yang Z., Zhang Y., Wang L., Dong M., Zhao J., Mu J., Meng Y., Effect of quercetin in the 1-Methyl-4phenyl-1,2,3,6-tetrahyropyridine- induced mouse model of Parkinson's disease. Evidence Based Complement and Alternative Medicine 2012 2012 928643
142. Mukai R., Kawabata K., Otsuka S., Effect of quercetin and its glucuronide metabolite upon 6-hyroxydopamine-induced oxidative damage in Neuro-2a cells. Free Radical Research 2012 46 8 1019 1028
143. Kääriäinen T. M., Piltonen M., Ossola B., Kekki H., Lehtonen Š.., Nenonen T., Lecklin A., Raasmaja A., Männistö P. T., Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures. Brain Research 2008 1203 149 159 2-s2.0-40949085989 10.1016/j.brainres.2008.01.089
144. Mu X., He G., Cheng Y., Li X., Xu B., Du G., Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Pharmacology Biochemistry and Behavior 2009 92 4 642 648 2-s2.0-67349270928 10.1016/j.pbb.2009.03.008
145. Filomeni G., Graziani I., Zio D. D., Dini L., Centonze D., Rotilio G., Ciriolo M. R., Neuroprotection of kaempferol by autophagy in models of rotenone-mediated acute toxicity: possible implications for Parkinson's disease. Neurobiology of Aging 2010 2-s2.0-77953910649 10.1016/j.neurobiolaging.2010.05. 021
146. Vauzour D., Corona G., Spencer J. P. E., Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. Archives of Biochemistry and Biophysics 2010 501 1 106 111 2-s2.0-77956174569 10.1016/j.abb.2010.03.016
147. Tai K. K., Truong D. D., (-)-Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, reduces dichlorodiphenyl-trichloroethane (DDT)-induced cell death in dopaminergic SHSY-5Y cells. Neuroscience Letters 2010 482 3 183 187 2-s2.0-77955920210 10.1016/j.neulet.2010.06.018
148. Ho D. J., Calingasan N. Y., Wille E., Dumont M., Beal M. F., Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Experimental Neurology 2010 225 1 74 84 2-s2.0-77955660387 10.1016/j.expneurol. 2010.05.006
149. Kim H. G., Ju M. S., Shim J. S., Kim M. C., Lee S. H., Huh Y., Kim S. Y., Oh M. S., Mulberry fruit protects dopaminergic neurons in toxin-induced Parkinson's disease models. The British Journal of Nutrition 2010 104 1 8 16 2-s2.0-77954687171 10.1017/S0007114510000218
150. Maher P., Dargusch R., Bodai L., Gerard P. E., Purcell J. M., Marsh J. L., Erk activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Human Molecular Genetics 2011 20 2 261 270 2-s2.0-78650525484 10.1093/hmg/ddq460
151. Kumar P., Kumar A., Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide. Behavioural Brain Research 2010 206 1 38 46 2-s2.0-70350196372 10.1016/j.bbr.2009.08.028
152. Hickey M. A., Zhu C., Medvedeva V., Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease. Molecular Neurodegeneration 2003 4 7 7 12
153. Ehrnhoefer D. E., Duennwald M., Markovic P., Wacker J. L., Engemann S., Roark M., Legleiter J., Marsh J. L., Thompson L. M., Lindquist S., Muchowski P. J., Wanker E. E., Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for down syndrome. Human Molecular Genetics 2006 15 18 2752 2762 2-s2.0-33748744375
154. Wang J., Pfleger C. M., Friedman L., Vittorino R., Zhao W., Qian X., Conley L., Ho L., Pasinetti G. M., Potential application of grape derived polyphenols in huntington's disease. Translational Neuroscience 2010 1 2 95 100 2-s2.0-79952338055 10.2478/v10134-010-0022-y
155. Sueishi Y., Ishikawa M., Yoshioka D., Oxygen radical absorbance capacity (ORAC) of cyclodextrin-solubilized flavonoids, resveratrol and astaxanthin as measured with ORAC-EPR method. Journal of Clinical Biochemistry and Nutrition 2012 50 2 127 132
156. Chang C. C., Chang C. Y., Huang J. P., Hung L. M., Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin- induced type 1diabetic rats. The Chinese Journal of Physiology 2012 55 3 192 201
157. Mikula-Pietrasik J., Kuczmarska A., Rubis B., Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radical Biology and Medicine 2012 52 11-12 2234 2245
158. Gresele P., Pignatelli P., Guglielmini G., Carnevale R., Mezzasoma A. M., Ghiselli A., Momi S., Violi F., Resveratrol, at concentrations attainable with moderate wine consumption, stimulates human platelet nitric oxide production. Journal of Nutrition 2008 138 9 1602 1608 2-s2.0-51049085099
159. Akhlaghi M., Bandy B., Preconditioning and acute effects of flavonoids in protecting cardiomyocytes from oxidative cell death. Oxidative Medicine and Cellular Longevity 2012 2012 9 782321 10.1155/2012/782321
160. Brückner M., Westphal S., Domschke W., Kucharzik T., Lügering A., Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis. Journal of Crohn's and Colotis 2012 6 2 226 235
161. Xie T., Wang W. P., Mao Z. F., Qu Z. Z., Luan S. Q., Jia L. J., Kan M. C., Effects of epigallocatechin-3-gallate on pentylenetetrazole-inducing kindling, cognitive impairment and oxidative stress in rats. Neuroscience Letters 2012 516 2 237 241
162. Liu C. M., Ma J. Q., Sun Y. Z., Puerarin protects rat kidney from leas-induced apoptosis by modulating the P13K/Akt/Enos pathway. Toxicology and Applied Pharmacology 2012 258 3 330 342
163. Ai Z. L., Zhang W. S., Yao S. K., Xie B. S., Gao C., Effect of baicalin on liver fatty acid binding protein in oxidative stress model in vitro. Zhonghua Gan Zang Bing Za Zhi 2011 19 12 927 931
164. Castañer O., Covas M. I., Khymenets O., Protection of LDL from oxidation by olive oil polyphenols is associated with a downregulation of CD40-ligand expression and its downstream products in vivo in humans. The American Journal of Clinical Nutrition 2012 95 5 1238 1244
165. Karlsen A., Paur I., Bøhn S. K., Sakhi A. K., Borge G. I., Serafini M., Erlund I., Laake P., Tonstad S., Blomhoff R., Bilberry juice modulates plasma concentration of NF- B related inflammatory markers in subjects at increased risk of CVD. European Journal of Nutrition 2010 49 6 345 355 2-s2.0-77955852925 10.1007/s00394-010-0092-0
166. Kesse-Guyot E., Fezeu L V. A., Andreeva, Touvier M., Scalbert A., Hercberg S., Galan P., Total and specific polyphenol intake in midlife are associated with cognitive function measured 13 years later. The Journal of Nutrition 2012 142 1 76 83
167. Morillas-Ruiz J. M., Rubio-Perez J. M., Albaladejo M. D., Zafrilla P., Parra S., Vidal-Guevara M. L., Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients. Journal of the Neurological Sciences 2010 299 1-2 175 178 2-s2.0-78649496830 10.1016/j.jns.2010.08.050
168. Xue X., Qu X. J., Yang Y., Sheng X. H., Cheng F., Jiang E. N., Wang J. H., Bu W., Liu Z. P., Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor B p65 activation. Biochemical and Biophysical Research Communications 2010 403 3-4 398 404 2-s2.0-78650170987 10.1016/j.bbrc.2010.11.042
169. Shin B. Y., Jin S. H., Chou I. J., Ki S. H., Nrf2-ARE pathway regulates induction of Sestrin-2 expression. Free Radical Biology and Medicine 2012 53 4 834 841
170. Li J., Ye L., Wang X., (-)-Epigallocatechin gallate inhibits endotoxin-induced expression of inflammatory cytokines in human cerebral microvascular endothelial cells. Journal of Neuroinflammation 2012 9 161 1 13
171. Saha A., Sarkar C., Singh S. P., Zhang Z., Munasinghe J., Peng S., Chandra G., Kong E., Mukherjee A. B., The blood brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol. Human Molecular Genetics 2012 21 10 2233 2244
172. Shukitt-Hale B., Lau F. C., Carey A. N., Galli R. L., Spangler E. L., Ingram D. K., Joseph J. A., Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutritional Neuroscience 2008 11 4 172 182 2-s2.0-50449095115 10.1179/147683008X301487
173. Jung M., Triebel S., Anke T., Richling E., Erkel G., Influence of apple polyphenols on inflammatory gene expression. Molecular Nutrition and Food Research 2009 53 10 1263 1280 2-s2.0-70350026412 10.1002/mnfr.200800575
174. Ansó E., Zuazo A., Irigoyen M., Urdaci M. C., Rouzaut A., Martínez-Irujo J. J., Flavonoids inhibit hypoxia-induced vascular endothelial growth factor expression by a HIF-1 independent mechanism. Biochemical Pharmacology 2010 79 11 1600 1609 2-s2.0-77950089188 10.1016/j.bcp.2010.02.004
175. Shin J. A., Lee K. E., Kim H. S., Park E. M., Acute resveratrol treatment modulates multiple signaling pathways in the ischemic brain. Neurochemical Research 2012 37 12 2686 2696
176. Bonda D. J., Lee H., Blair J. A., Zhu X., Perry G., Smith M. A., Role of metal dyshomeostasis in Alzheimer's disease. Metallomics 2011 3 267 270
177. Schneider S. A., Hardy J., Bhatia K. P., Syndromes of neurodegeneration with brain iron accumulation (NBIA): an update on clinical presentations, histological and genetic underpinnings and treatment considerations. Movement Disorders 2012 27 1 42 53
178. Avramovich-Tirosh Y., Reznichenko L., Amit T., Zheng H., Fridkin M., Weinreb O., Mandel S., Youdim M. B. H., Neurorescue activity, APP regulation and amyloid- β peptide reduction by novel multi-functional brain permeable iron-chelating-antioxidants, M-30 and green tea polyphenol, EGCG. Current Alzheimer Research 2007 4 4 403 411 2-s2.0-34548695421 10.2174/ 156720507781788927
179. Reznichenko L., Amit T., Zheng H., Avramovich-Tirosh Y., Youdim M. B. H., Weinreb O., Mandel S., Reduction of iron-regulated amyloid precursor protein and β -amyloid peptide by (-)-epigallocatechin-3-gallate in cell cultures: implications for iron chelation in Alzheimer's disease. Journal of Neurochemistry 2006 97 2 527 536 2-s2.0-33645294934 10.1111/j.1471-4159.2006. 03770.x
180. Pirker K. F., Baratto M. C., Bososi R., Goodman B. A., Influence of pH on the speciation of copper (II) in reactions with the green tea polyphenols, epigallocatechin gallate and gallic acid. Journal of Inorganic Biochemistry 2012 112 10 16
181. Dairam A., Fogel R., Daya S., Limson J. L., Antioxidant and iron-binding properties of curcumin, capsaicin, and S-allylcysteine reduce oxidative stress in rat brain homogenate. Journal of Agricultural and Food Chemistry 2008 56 9 3350 3356 2-s2.0-44349191658 10.1021/jf0734931
182. Du X. X., Xu H. M., Jiang H., Song N., Wang J., Xie J. X., Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hyroxydopamine rat model of Parkinson's disease. Neuroscience Bulletin 2012 28 3 253 258
183. Tripanichkul W., Jaroensuppaperch E. O., Curcumin protects nigrostriatal dopaminergic neurons and reduces glial activation in 6-hyroxydopmanine hemiparkinsonian mice model. The International Journal of Neuroscience 2012 122 5 263 270
184. Wang J., Du X. X., Jiang H., Xie J. X., Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappaB modulation in MES23.5 cells. Biochemical Pharmacology 2009 78 2 178 183 2-s2.0-65649105139 10.1016/j.bcp.2009.03.031
185. Ren J., Fan C., Chen N., Huang J., Yang Q., Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf-2 and HO-1 in rats. Neurochemical Research 2011 36 12 2352 2362
186. Wang J., Xu H., Jiang H., Du X., Su P., Xie J., Neurorescue effect of rosmaric acid on 6-hyroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson's disease. Journal of Molecular Neuroscience 2012 47 1 113 119
187. Rambold A. S., Miesbauer M., Olschewski D., Seidel R., Riemer C., Smale L., Brumm L., Levy M., Gazit E., Oesterhelt D., Baier M., Becker C. F. W., Engelhard M., Winklhofer K. F., Tatzelt J., Green tea extracts interfere with the stress-protective activity of PrPC and the formation of PrPSc. Journal of Neurochemistry 2008 107 1 218 229 2-s2.0-51849093033 10.1111/j.1471-4159.2008. 05611.x
188. Jeong J. K., Moon M. H., Bae B. C., Autophagy induced by resveratrol prevents human prion protein mediated neurotoxicity. Neurochemical Research 2012 73 2 99 105
189. Bizat N., Peyrin J. M., Haïk S., Cochois V., Beaudry P., Laplanche J. L., Néri C., Neuron dysfunction is induced by prion protein with an insertional mutation via a fyn kinase and reversed by sirtuin activation in Caenorhabditis elegans. Journal of Neuroscience 2010 30 15 5394 5403 2-s2.0-77950968403 10.1523/JNEUROSCI.5831-09.2010
190. Hafner-Bratkovic I., Gaspersic J., Smid L. M., Bresjanac M., Jerala R., Neuron dysfunction is induced by prion protein with an insertional mutation via a Fyn kinase and reversed by sirtuin activation in Caenorhabiditis elegans. Journal of Neurochemistry 2010 30 15 5394 5403 2-s2.0-50849101961
191. Khan M. T. H., Orhan I., Şenol F. S., Kartal M., Şener B., Dvorská M., Šmejkal K., Šlapetová T., Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their modecular docking studies. Chemical Biological Interactions 2009 181 3 383 389 2-s2.0-70249147178 10.1016/j.cbi.2009.06.024
192. Girones-Vilaplana A., Valentao P., Andrade P. B., Ferreres F., Moreno D. A., Garcia-Viguera C., Phytochemical profile of a blend of black chokeberry and lemon juice with cholinesterase inhibitory effect and antioxidant potential. Food Chemistry 2012 134 2090 2096
193. Ryu H. W., Curtis-Long M. J., Jung S., Anticholinesterase potential of flavonols from paper mulberry (Broussonetia papyrifera) and their kinetic studies. Food Chemistry 2012 132 3 1244 1250
194. Papandreou M. A., Dimakopoulou A., Linardaki Z. I., Cordopatis P., Klimis-Zacas D., Margarity M., Lamari F. N., Effect of a polyphenol-rich wild blueberry extract on cognitive performance of mice, brain antioxidant markers and acetylcholinesterase activity. Behavioural Brain Research 2009 198 2 352 358 2-s2.0-59649099426 10.1016/j.bbr.2008.11.013
195. Cho J. K., Ryu Y. B., Curtis-Long M. J., Cholinesterase inhibitory effects of geranylated flavonoids from Paulownia tomentosa fruits. Bioinorganic and Medicinal Chemistry 2012 20 8 2595 2602
196. Choi G. N., Kim J. H., Kwak J. H., Effect of quercetin on learning and memory performance in ICR mice under neurotoxic trimethyltin exposure. Food Chemistry 2012 132 2 1019 1024
197. Tota S., Awasthi H., Kamat P. K., Nath C., Hanif K., Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behavioural Brain Research 2010 209 1 73 79 2-s2.0-77249130189 10.1016/j.bbr.2010.01.017
198. Akkol E. K., Orhan I. O., Yesilada E., Anticholinesterase and antioxidant effects of the ethanol extract, ethanol fractions and isolated flavonoids from Cistus laurifolius L. leaves. Food Chemistry 2012 131 2 626 631
199. Porfírio S., Falé P. L. V., Madeira P. J. A., Florêncio M. H., Ascensão L., Serralheiro M. L. M., Antiacetylcholinesterase and antioxidant activities of Plectranthus barbatus tea, after in vitro gastrointestinal metabolism. Food Chemistry 2010 122 1 179 187 2-s2.0-77950593812 10.1016/j.foodchem.2010.02.044
200. Guo A. J. Y., Xie H. Q., Choi R. C. Y., Zheng K. Y. Z., Bi C. W. C., Xu S. L., Dong T. T. X., Tsim K. W. K., Galangin, a flavonol derived from Rhizoma Alpiniae Officinarum, inhibits acetylcholinesterase activity in vitro. Chemico-Biological Interactions 2010 187 1-3 246 248 2-s2.0-77955511213 10.1016/j.cbi.2010.05.002
201. Xiao J., Chen X., Zhang L., Talbot S. G., Li G. C., Xu M., Investigation of the Mechanism of enhances effect of EGCG on huperzine A's inhibition of acetylcholinesterase activity in rats by a multispectroscopic method. Journal of Agricultural and Food Chemistry 2008 56 910 915
202. Zhang L., Cao H., Wen J., Xu M., Green tea polyphenol (-)-epigallocatechin-3-gallate enhances the inhibitory effect of huperzine A on acetylcholinesterase by increasing the affinity with serum albumin. Nutritional Neuroscience 2009 12 4 142 148 2-s2.0-70350459571 10.1179/147683009X423283
203. Lou H., Fan P., Perez R. G., Lou H., Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid- β -induced neuronal cell death. Bioorganic and Medicinal Chemistry 2011 19 13 4021 4027 2-s2.0-79959521714 10.1016/j.bmc.2011.05.021
204. Huang S. M., Tsai S. Y., Lin J. A., Wu C. H., Yen G. C., Cytoprotective effects of hesperetin and hesperidin against amyloid β -induced impairment of glucose transport through downregulation of neuronal autophagy. Molecular Nutrition and Food Research 2012 56 4 601 609
205. Wu Y., Li X., Zhu J. X., Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals 2011 19 3 163 174
206. Li Z., Pang L., Fang F., Resveratrol attenuates brain damage in a rat model of focal ischemia via up-regulation of hippocampal Bcl-2. Brain Research 2012 1450 116 124
207. Kairisalo M., Bonomo A., Hyrskyluoto A., Mudò G., Belluardo N., Korhonen L., Lindholm D., Resveratrol reduces oxidative stress and cell death and increases mitochondrial antioxidants and XIAP in PC6.3-cells. Neuroscience Letters 2011 488 3 263 266 2-s2.0-78650957644 10.1016/j.neulet.2010.11.042
208. Ploai C., Antoniou X., Sclip A., JNK plays a key role in tau hyperphosphorylation in Alzheimet's disease models. Journal of Alzheimer's Research 2011 26 2 315 329
209. 2 semiquinones and quinones. Free Radical Biology and Medicine 2011 51 12 2319 2327
210. Zhang W., Go M. L., Methoxylation of resveratrol: effects on induction of NAD(P)H Quinone-oxidoreductase 1 (NQO1) activity and growth inhibitory properties. Bioorganic and Medicinal Chemistry Letters 2011 21 3 1032 1035 2-s2.0-78751646363 10.1016/j.bmcl.2010.12.029
211. Karbowski M., Jeong S. Y., Youle R. J., Endophilin B1 is required for the maintenance of mitochondrial morphology. Journal of Cell Biology 2004 166 7 1027 1039 2-s2.0-4644242944 10.1083/jcb.200407046
212. Ahn J. I., Jeong K. J., Ko M. J., Shin H. J., Kim H. S., Chung H. J., Jeong H. S., Changes of miRNA and mRNA expression in HepG2 cells treated by epigallocatechin gallate. Molecular and Cellular Toxicology 2010 6 2 169 177 2-s2.0-77956587688 10.1007/s13273-010-0024-3
213. Wallace C. H. R., Baczkó I., Jones L., Fercho M., Light P. E., Inhibition of cardiac voltage-gated sodium channels by grape polyphenols. British Journal of Pharmacology 2006 149 6 657 665 2-s2.0-33751014319 10.1038/sj.bjp.0706897
214. Ma D., Zerangue N., Raab-Graham K., Fried S. R., Jan Y. N., Jan L. Y., Diverse trafficking patterns due to multiple traffic motifs in G protein-activated inwardly rectifying potassium channels from brain and heart. Neuron 2002 33 5 715 729 2-s2.0-0037186091 10.1016/S0896-6273(02)00614-1
215. Yow T. T., Pera E., Absalom N., Heblinski M., Johnston G. A., Hanrahan J. R., Chebib M., Naringin directly activates inwardly rectifying potassium channels at an overlapping binding site to tertiapin-Q. British Journal of Pharmacology 2011 163 5 1017 1033 2-s2.0-79958796157 10.1111/j.1476-5381.2011. 01315.x
216. 2+ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neurons. International Journal of Molecular Sciences 2011 12 1 742 754 2-s2.0-79251628168 10.3390/ijms12010742
217. + channels by curcumin in Jurkat-T cells. Journal of Pharmacological Sciences 2011 115 2 144 154 2-s2.0-79952344333 10.1254/jphs.10209FP
218. Wu Y. L., Ohsaga A., Oshiro T., Iinuma K., Kondo Y., Ebihara S., Sasaki H., Maruyama Y., Suppressive effects of red wine polyphenols on voltage-gated ion channels in dorsal root ganglionic neuronal cells. Tohoku Journal of Experimental Medicine 2005 206 2 141 150 2-s2.0-21244458041 10.1620/tjem.206.141